Immunohistochemical expression of HGF and cMET in meningiomas
Mariam Ibrahim Halim Ibrahim;
Abstract
Background: Meningiomas are the most common intracranial neoplasm together with gliomas; but unlike gliomas they are still graded according to their histopathological picture. Many growth factors and tyrosine kinase receptors have been studied in meningiomas in an attempt for prognostic stratification of patients, also to find a suitable targeted therapy for meningiomas.
Aim of the study: To correlate the immunohistochemical expression of HGF and cMET with the different WHO grades of meningioma in addition to brain invasion. All cases were subjected to immunohistochemical staining by HGF and cMET.
Materials and methods: This study included 60 cases of meningiomas (WHO grade I, n=30 and WHO grade II & III, n=30), brain invasion was present in 14 cases.
Results: HGF, cMET & HGF/cMET co-expression were positive in 60.0%, 65.0% and 58.3% respectively of the cases; WHO grade I meningioma showed positivity in 30.0%, 33.3% and 30.0% of the cases respectively in contrast with 90.0%, 96.7% and 86.7% of the cases of WHO grades II & III meningiomas respectively. Therefore, high risk meningiomas were associated with higher expression of the markers with a statistically highly significant relation (P- value: <0.001). As regards cases with brain invasion the expression of HGF, cMET and HGF/cMET co-expression was found in 92.9%, 100.0% and 92.9% respectively in comparison with 50.0%, 54.3% and 47.8% in the rest of the cases of meningiomas respectively. Therefore, brain invasive meningiomas were associated with higher expression of the markers with a statistically highly significant relation (P- value: 0.004).
Conclusion: The results suggest that HGF/cMET pathway may play a role in the progression of meningiomas from WHO grade I to higher grades II & III.
Aim of the study: To correlate the immunohistochemical expression of HGF and cMET with the different WHO grades of meningioma in addition to brain invasion. All cases were subjected to immunohistochemical staining by HGF and cMET.
Materials and methods: This study included 60 cases of meningiomas (WHO grade I, n=30 and WHO grade II & III, n=30), brain invasion was present in 14 cases.
Results: HGF, cMET & HGF/cMET co-expression were positive in 60.0%, 65.0% and 58.3% respectively of the cases; WHO grade I meningioma showed positivity in 30.0%, 33.3% and 30.0% of the cases respectively in contrast with 90.0%, 96.7% and 86.7% of the cases of WHO grades II & III meningiomas respectively. Therefore, high risk meningiomas were associated with higher expression of the markers with a statistically highly significant relation (P- value: <0.001). As regards cases with brain invasion the expression of HGF, cMET and HGF/cMET co-expression was found in 92.9%, 100.0% and 92.9% respectively in comparison with 50.0%, 54.3% and 47.8% in the rest of the cases of meningiomas respectively. Therefore, brain invasive meningiomas were associated with higher expression of the markers with a statistically highly significant relation (P- value: 0.004).
Conclusion: The results suggest that HGF/cMET pathway may play a role in the progression of meningiomas from WHO grade I to higher grades II & III.
Other data
| Title | Immunohistochemical expression of HGF and cMET in meningiomas | Other Titles | التعبير المناعي الهيستوكيميائي للدلالات HGF وcMET في الأورام السحائية | Authors | Mariam Ibrahim Halim Ibrahim | Issue Date | 2020 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.